Scope Laboratories Private Limited - Due diligence report

A 360° intelligence report on Scope Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth …

1995-07-14 Bangalore, Karnataka Active Unlisted
Share
SL Scope Laboratories Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Scope Laboratories Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
66/100
Trust Score
Moderate

Scope Laboratories Private Limited is assessed as Moderate with a Trust Score of 66/100. Scope Laboratories Private Limited is an active private limited indian non-government company incorporated in 1995, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Scope Laboratories Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 2 satisfied (8.75 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Ltd1 48.0 cr
Indian Bank1 48.0 cr
Compliance Score: 45/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2022 - filings overdue.
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KUMAR AMUDHA 01234567 Director 01/04/2018 6 yrs Approved
RAJESH MANOHARLAL TALREJA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 45
Growth signals & trust indicators
Operating for 31+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence51/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view57/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
29 Apr 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
08 Mar 2021
Director ceased
RINKU DESHPANDE
Director ceased
NILESH RATNAKAR DESHPANDE
25 Jan 2021
Director appointed
KUMAR AMUDHA (Director)
Director appointed
RAJESH MANOHARLAL TALREJA (Director)
23 Dec 2013
Charge satisfied
Axis Bank Ltd
05 Dec 2013
Securities allotted
4990.00 Equity Shares - 49.90 Lakh raised
26 Oct 2013
Charge satisfied
Indian Bank
20 Jul 2013
Director ceased
RINKU PRAKASH TALREJA
18 Dec 2007
Charge created
Axis Bank Ltd - 5.50 cr
03 Apr 2007
Charge created
Indian Bank - 3.25 cr
14 Jul 1995
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 3 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Japna Chemicals Private Limited U24100DL1996PTC081963 Delhi, Delhi, India
Utek Health Care Private Limited U24230MH2003PTC139340 Mumbai, Maharashtra, India
Palem Organics Private Limited U24299TG2020PTC144367 Hyderabad, Telangana, India
The Green Maven U74999MH2017PTC296627 Mumbai, Maharashtra, India
Bhilad Chemicals Private Limited U24220GJ2004PTC122339 Sarigam, Gujarat, India
Astaberry Biosciences (India) Private Limited U74899DL1979PTC009910 New Delhi, Delhi, India
Chemcare Life Sciences Private Limited U24232RJ2015PTC047571 Udaipur, Rajasthan, India
Eskay Chemical Equipment Works Pvt Ltd U29297WB1980PTC032468 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Scope Laboratories Private Limited before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Scope Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Scope Laboratories Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Scope Laboratories Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Scope Laboratories Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Scope Laboratories Private Limited an active company?

Scope Laboratories Private Limited has MCA status “Active” with a compliance score of 45/100 (Caution Indicated).

Is Scope Laboratories Private Limited financially healthy?

Scope Laboratories Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Scope Laboratories Private Limited?

Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Scope Laboratories Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Scope Laboratories Private Limited have loans or charges against its assets?

No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Scope Laboratories Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Scope Laboratories Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.